Literature DB >> 9202797

Serum C-reactive protein levels in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan.

H Koyanagi1, H Yanagawa, Y Nakamura, M Yashiro.   

Abstract

Thirteen nation-wide epidemiological surveys of Kawasaki disease have been carried out successively since 1970 in Japan. In the latest survey, questionnaires on serum C-reactive protein (CRP) levels of the patients were included to clarify whether serum CRP levels could be available for the diagnosis and prediction of prognosis. A questionnaire from and diagnostic guidelines for Kawasaki disease were sent to all paediatric departments of hospitals with 100 or more beds throughout Japan, and information including maximal serum CRP levels was obtained on patients with Kawasaki disease diagnosed during the 2-year period from January 1993 to December 1994. Of the 11458 patients diagnosed during the 2-year period, maximal serum CRP levels were reported in 11040 patients (96.4%). The values of maximal serum CRP were higher in the age groups < 6 months and > 2 years. The mean value and the distribution of serum CRP levels in-suspected cases were lowest among the three diagnostic categories and this difference among diagnostic categories was highly significant in the age groups 6 M-1 Y and 1-2 Y. The proportion of patients with cardiac sequelae increased with serum CRP levels in each age group. The mean value and the distribution of serum CRP levels of the patients with cardiac sequelae was higher than those without it and this difference between cardiac prognoses was outstanding in the age groups 6 M-1 Y and < 6 M. The Receiver/Response Operating Characteristic (ROC) curve for maximal serum CRP levels in Kawasaki disease revealed that accuracy of maximal serum CRP levels for prediction of cardiac sequelae was highest in the age group 6 M-1 Y. A large-scale observation and analysis of serum CRP levels of the patients with Kawasaki disease revealed age-dependent relationships among maximal serum CRP levels, diagnostic categories and prognosis. Serum CRP levels may be helpful for the prediction of prognosis with the consideration of age.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202797     DOI: 10.1111/j.1651-2227.1997.tb08944.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Serum sodium levels in patients with Kawasaki disease.

Authors:  H Muta; M Ishii; K Egami; S Hayasaka; Y Nakamura; H Yanagawa; T Matsuishi
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  Immunoglobulin Resistance in Kawasaki Disease.

Authors:  Georgios A Hartas; Syed Shahrukh Hashmi; Chi Pham-Peyton; Emmanouil Tsounias; John T Bricker; Monesha Gupta-Malhotra
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-03-01       Impact factor: 1.349

Review 3.  Endothelial function in pre-pubertal children at risk of developing cardiomyopathy: a new frontier.

Authors:  Aline Cristina Tavares; Edimar Alcides Bocchi; Guilherme Veiga Guimarães
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

4.  Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.

Authors:  Masanari Kuwabara; Mayumi Yashiro; Kazuhiko Kotani; Satoshi Tsuboi; Ryusuke Ae; Yosikazu Nakamura; Hiroshi Yanagawa; Tomisaku Kawasaki
Journal:  J Epidemiol       Date:  2015-01-10       Impact factor: 3.211

5.  Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.

Authors:  Zhenquan Wang; Fengfeng Weng; Chen Li; Hongying Shi; Zhangke Tang; Huixian Qiu; Yue'e He; Rongzhou Wu; Maoping Chu
Journal:  BMC Pediatr       Date:  2018-02-21       Impact factor: 2.125

Review 6.  Kawasaki Disease in the neonate: case report and literature review.

Authors:  Fajer Altammar; Bianca Lang
Journal:  Pediatr Rheumatol Online J       Date:  2018-07-03       Impact factor: 3.054

7.  The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study.

Authors:  Hyo Soon An; Gi Beom Kim; Mi Kyoung Song; Sang Yun Lee; Hye Won Kwon; Joo Won Lee; Eun Jung Bae
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-02       Impact factor: 3.054

8.  Multimeric stability of human C-reactive protein in archived specimens.

Authors:  Qiling Li; Ting Kang; Xiaohua Tian; Yamin Ma; Min Li; Jendai Richards; Tameka Bythwood; Yueling Wang; Xu Li; Dong Liu; Li Ma; Qing Song
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

9.  Receptor for advanced glycation end products involved in circulating endothelial cells release from human coronary endothelial cells induced by C-reactive protein.

Authors:  Shulai Zhou; Lichao Gao; Fangqi Gong; Xiaoyang Chen
Journal:  Iran J Basic Med Sci       Date:  2015-06       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.